Avantor, Inc. filed 5 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-21. Between them they name 2 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Todd Garner
Upon the Commencement Date, Mr. Garner will become a member of the Company's Executive Leadership Team and serve as its principal financial officer.
Appointed: Todd Garner
Upon the Commencement Date, Mr. Garner will become a member of the Company's Executive Leadership Team and serve as its principal financial officer.
Reported
On April 23, 2026, Avantor, Inc. (the "Company") filed a Current Report on Form 8-K (the "Original 8-K") disclosing that Benoit Gourdier, the Company's Executive Vice President, Bioscience and Medtech Products, would transition to a new role supporting the Company's segment integration activities for a period of time, after which he would depart the Company.
Reported
On April 17, 2026, Avantor, Inc. (the "Company") informed Benoit Gourdier, the Company's Executive Vice President, Bioscience and Medtech Products, that he would be transitioning to a new role supporting the Company's segment integration activities, after which it is expected that he would depart the Company no later than December 31, 2026.
Departing: R. Brent Jones, Chief Financial Officer
On March 26, 2026, Mr. R. Brent Jones notified Avantor, Inc. (the "Company") of his decision to resign as the Company's Executive Vice President and Chief Financial Officer ("CFO") to join a company outside the life sciences industry.
Find people with the same kind of experience as the Chief Financial Officer at Avantor, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Avantor, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Avantor, Inc. is in the news or changes leadership.
Get an alert when Avantor, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Avantor, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
